Stay updated on Tucatinib Combo Efficacy in HER2+ Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Tucatinib Combo Efficacy in HER2+ Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Tucatinib Combo Efficacy in HER2+ Breast Cancer Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    The page’s footer software revision label was updated from v3.5.2 to v3.5.3, indicating a minor site/version change rather than a change to the trial record content.
    Difference
    0.1%
    Check dated 2026-04-24T06:31:05.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    Added revision v3.5.2 and removed revision v3.5.0 from the study record history.
    Difference
    0.1%
    Check dated 2026-04-17T02:46:51.000Z thumbnail image
  4. Check
    25 days ago
    No Change Detected
  5. Check
    40 days ago
    Change Detected
    Summary
    On 2026-03-02, the record adds Adverse Events, Outcome Measures (Results), Baseline Characteristics, Participant Flow, Outcome Measures, and Study Status, while a previous entry was deleted on 2025-09-30.
    Difference
    0.5%
    Check dated 2026-03-26T11:55:33.000Z thumbnail image
  6. Check
    47 days ago
    Change Detected
    Summary
    Revision v3.5.0 was added and revision v3.4.3 was removed from the record history.
    Difference
    0.1%
    Check dated 2026-03-19T06:35:54.000Z thumbnail image
  7. Check
    54 days ago
    Change Detected
    Summary
    Revision history updated: added Revision v3.4.3 and deleted Revision v3.4.2.
    Difference
    0.1%
    Check dated 2026-03-12T02:17:55.000Z thumbnail image
  8. Check
    83 days ago
    Change Detected
    Summary
    Added revision entry v3.4.2 to the history; removed a government funding operating status notice and the earlier revision v3.4.1.
    Difference
    0.4%
    Check dated 2026-02-11T12:18:18.000Z thumbnail image

Stay in the know with updates to Tucatinib Combo Efficacy in HER2+ Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Tucatinib Combo Efficacy in HER2+ Breast Cancer Clinical Trial page.